Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate
Ovidiu C. Andronesi(Harvard University), Tracy T. Batchelor(Brigham and Women's Hospital)
Cited by 144
Related Papers
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment
|Cancer Cell|2018|263
Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
|Cancer Discovery|2014|251
Phase II Trial of Thalidomide and Carmustine for Patients With Recurrent High-Grade Gliomas
|Journal of Clinical Oncology|2003|174